HK40019395A - 组合治疗 - Google Patents
组合治疗 Download PDFInfo
- Publication number
- HK40019395A HK40019395A HK42020009225.2A HK42020009225A HK40019395A HK 40019395 A HK40019395 A HK 40019395A HK 42020009225 A HK42020009225 A HK 42020009225A HK 40019395 A HK40019395 A HK 40019395A
- Authority
- HK
- Hong Kong
- Prior art keywords
- cancer
- inhibitor
- alkyl
- combination
- antibody
- Prior art date
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62/059,832 | 2014-10-03 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18102008.6A Addition HK1242582B (zh) | 2014-10-03 | 2015-10-02 | 组合治疗 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18102008.6A Division HK1242582B (zh) | 2014-10-03 | 2015-10-02 | 组合治疗 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK40019395A true HK40019395A (zh) | 2020-10-16 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240075136A1 (en) | Combination therapies | |
| US20210000951A1 (en) | Combination therapies | |
| US20200030442A1 (en) | Combination therapies | |
| JP2022191239A (ja) | Ｖｉｓｔａ及びｐｄ－１経路の二重阻害剤 | |
| CA2936962A1 (en) | Antibody molecules to lag-3 and uses thereof | |
| CN106103485A (zh) | Pd‑1的抗体分子及其用途 | |
| HK40019395A (zh) | 组合治疗 | |
| HK1242582A1 (zh) | 组合治疗 | |
| HK1242582B (zh) | 组合治疗 |